CRNX

#1312
Crinetics Pharmaceuticals, Inc. - Common Stock
35.5 5 USD
-1.28%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
35.55
35.55
Range Annuel
0.36
57.99
Changement quotidien
-1.28%
Changement Mensuel
-7.45%
Evolution sur 6 mois
-21.00%
Changement Annuel
-13.50%
Clôture Précédente
36.0 1
Open
35.5 5
Low
35.5 5
High
35.5 5
Volume
148
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 3.75 B
  • Employee 594
  • Founded 2008
  • CEO N/A
  • Website www.crinetics.com
  • Headquarter Delaware, United States
  • FIGI BBG00BC59224
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-9.4
ratio cours/chiffre d'affaires
568.91

Crinetics Pharmaceuticals, Inc. - Common Stock

Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.

Nouvelles